$228.31 Million in Sales Expected for Omega Healthcare Investors Inc (NYSE:OHI) This Quarter

Brokerages expect Omega Healthcare Investors Inc (NYSE:OHI) to report sales of $228.31 million for the current quarter, Zacks Investment Research reports. Four analysts have issued estimates for Omega Healthcare Investors’ earnings, with estimates ranging from $220.08 million to $233.70 million. Omega Healthcare Investors posted sales of $219.88 million in the same quarter last year, which suggests a positive year-over-year growth rate of 3.8%. The firm is scheduled to issue its next quarterly earnings report on Friday, August 2nd.

On average, analysts expect that Omega Healthcare Investors will report full-year sales of $923.17 million for the current year, with estimates ranging from $878.98 million to $950.59 million. For the next financial year, analysts forecast that the company will report sales of $995.34 million, with estimates ranging from $898.75 million to $1.05 billion. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for Omega Healthcare Investors.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings data on Tuesday, May 7th. The real estate investment trust reported $0.34 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.71 by ($0.37). Omega Healthcare Investors had a net margin of 30.17% and a return on equity of 7.02%. The firm had revenue of $188.20 million during the quarter, compared to analysts’ expectations of $190.54 million. During the same quarter in the prior year, the firm posted $0.78 EPS. Omega Healthcare Investors’s quarterly revenue was down 2.9% compared to the same quarter last year.

Several equities research analysts have recently commented on the company. Zacks Investment Research upgraded Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research note on Wednesday, May 1st. ValuEngine cut Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research note on Wednesday, April 3rd. Seven investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $37.05.

Shares of Omega Healthcare Investors stock traded down $0.61 during trading hours on Tuesday, hitting $37.04. 1,594,200 shares of the company were exchanged, compared to its average volume of 1,715,031. Omega Healthcare Investors has a 1 year low of $28.65 and a 1 year high of $40.30. The company has a quick ratio of 2.86, a current ratio of 2.86 and a debt-to-equity ratio of 1.16. The firm has a 50-day simple moving average of $36.63. The firm has a market capitalization of $7.86 billion, a PE ratio of 12.18, a price-to-earnings-growth ratio of 5.00 and a beta of 0.41.

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 10,000 shares of the stock in a transaction on Monday, May 13th. The stock was sold at an average price of $37.00, for a total value of $370,000.00. Following the completion of the transaction, the chief financial officer now owns 233,326 shares in the company, valued at $8,633,062. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO C Taylor Pickett sold 22,788 shares of the stock in a transaction on Monday, April 1st. The stock was sold at an average price of $38.04, for a total value of $866,855.52. Following the completion of the transaction, the chief executive officer now owns 329,133 shares of the company’s stock, valued at approximately $12,520,219.32. The disclosure for this sale can be found here. Insiders have sold 102,788 shares of company stock valued at $3,896,856 in the last 90 days. Company insiders own 1.16% of the company’s stock.

Large investors have recently added to or reduced their stakes in the business. JOYN Advisors Inc. raised its position in Omega Healthcare Investors by 58.4% in the fourth quarter. JOYN Advisors Inc. now owns 1,033 shares of the real estate investment trust’s stock worth $36,000 after acquiring an additional 381 shares in the last quarter. Massey Quick Simon & CO. LLC acquired a new stake in Omega Healthcare Investors in the first quarter valued at $38,000. Spirit of America Management Corp NY acquired a new stake in Omega Healthcare Investors in the first quarter valued at $38,000. Reilly Financial Advisors LLC grew its holdings in Omega Healthcare Investors by 68.1% in the first quarter. Reilly Financial Advisors LLC now owns 992 shares of the real estate investment trust’s stock valued at $38,000 after purchasing an additional 402 shares during the last quarter. Finally, Washington Trust Bank grew its holdings in Omega Healthcare Investors by 684.9% in the first quarter. Washington Trust Bank now owns 1,146 shares of the real estate investment trust’s stock valued at $44,000 after purchasing an additional 1,000 shares during the last quarter. Hedge funds and other institutional investors own 69.29% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Recommended Story: How to start trading in the forex market?

Get a free copy of the Zacks research report on Omega Healthcare Investors (OHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.